142 related articles for article (PubMed ID: 22984631)
21. Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.
Xiao M; Jia S; Wang H; Wang J; Huang Y; Li Z
J Cancer Res Clin Oncol; 2013 Apr; 139(4):661-7. PubMed ID: 23292099
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of LAPTM4B-35 in cervical carcinoma: a clinicopathologic study.
Meng F; Luo C; Hu Y; Yin M; Lin M; Lou G; Zhou R
Int J Gynecol Pathol; 2010 Nov; 29(6):587-93. PubMed ID: 20881850
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer.
Zhang H; Wei Q; Liu R; Qi S; Liang P; Qi C; Wang A; Sheng B; Li L; Xu Y
PLoS One; 2014; 9(3):e91069. PubMed ID: 24651764
[TBL] [Abstract][Full Text] [Related]
24. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer.
Liu Y; Zhang QY; Qian N; Zhou RL
Ann Oncol; 2007 Feb; 18(2):311-6. PubMed ID: 17074969
[TBL] [Abstract][Full Text] [Related]
25. LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors.
Yin M; Lou C; Zhang W; Meng F; Zhang H; Ning X; Zhou R; Dong X; Lou G
Int J Gynecol Cancer; 2012 Jan; 22(1):54-62. PubMed ID: 22193644
[TBL] [Abstract][Full Text] [Related]
26. LAPTM4B polymorphism is associated with non‑small cell lung cancer susceptibility and prognosis.
Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M; Hu W
Oncol Rep; 2014 May; 31(5):2454-60. PubMed ID: 24676601
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells.
Zhou L; He XD; Yu JC; Zhou RL; Shan Y; Rui JA
Surgery; 2011 Jul; 150(1):25-31. PubMed ID: 21429547
[TBL] [Abstract][Full Text] [Related]
28. Elevated lysosome-associated protein transmembrane-4β-35 is an independent prognostic marker in pancreatic carcinoma.
Zhang G; Liang Y; Huang Y; Chen Y; Zhou R
J Int Med Res; 2012; 40(4):1275-83. PubMed ID: 22971479
[TBL] [Abstract][Full Text] [Related]
29. Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population.
Wang B; Xu J; Zhou R; Zhang Q
Med Oncol; 2013 Mar; 30(1):470. PubMed ID: 23345117
[TBL] [Abstract][Full Text] [Related]
30. Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma.
Zhang LQ; Xu XS; Wan Y; Song SD; Wang RT; Chen W; Wang ZX; Chang HL; Wei JC; Dong YF; Liu C
World J Gastroenterol; 2015 Jan; 21(4):1243-50. PubMed ID: 25632198
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.
Zhang L; Wang R; Chen W; Xu X; Dong S; Fan H; Liu C
HPB (Oxford); 2016 Jul; 18(7):600-7. PubMed ID: 27346141
[TBL] [Abstract][Full Text] [Related]
32. Correlation of LAPTM4B polymorphisms with cervical carcinoma.
Meng F; Song H; Luo C; Yin M; Xu Y; Liu H; Zhou R; Lou G
Cancer; 2011 Jun; 117(12):2652-8. PubMed ID: 21656743
[TBL] [Abstract][Full Text] [Related]
33. Association between
Ding H; Cheng X; Ding N; Tian Z; Zhu J; Zhou C; Shen J; Song Y
Oncol Lett; 2018 Jan; 15(1):264-270. PubMed ID: 29387221
[TBL] [Abstract][Full Text] [Related]
34. Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients.
Li S; Wang L; Meng Y; Chang Y; Xu J; Zhang Q
Oncotarget; 2017 Jun; 8(25):41282-41293. PubMed ID: 28476037
[TBL] [Abstract][Full Text] [Related]
35. Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival.
Yadav A; Gupta A; Rastogi N; Agrawal S; Kumar A; Kumar V; Mittal B
Tumour Biol; 2016 Feb; 37(2):1835-44. PubMed ID: 26318430
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma.
Kotowski U; Kadletz L; Schneider S; Oberndorfer F; Schnoell J; Gurnhofer E; Kenner L; Lucas T; Heiduschka G
Sci Rep; 2019 Dec; 9(1):18866. PubMed ID: 31827181
[TBL] [Abstract][Full Text] [Related]
37. Association of TERT-CLPTM1L and 8q24 Common Genetic Variants with Gallbladder Cancer Susceptibility and Prognosis in North Indian Population.
Yadav S; Chandra A; Kumar A; Mittal B
Biochem Genet; 2018 Aug; 56(4):267-282. PubMed ID: 29450669
[TBL] [Abstract][Full Text] [Related]
38. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
Zhou N; Cheng W; Peng C; Liu Y; Jiang B
Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
[TBL] [Abstract][Full Text] [Related]
39. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
40. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.
Yang Y; Yang H; McNutt MA; Xiong F; Nie X; Li L; Zhou R
Oncol Rep; 2008 Nov; 20(5):1077-83. PubMed ID: 18949404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
